Immunotherapy

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 6/29/2021

Max Credits: 1

View Activity

Advancing Science in Sickle Cell Disease: Implications for the Future of Care

Advancing Science in Sickle Cell Disease: Implications for the Future of Care

Sickle cell disease (SCD) is a heterogeneous disorder characterized by sev…

Expiration Date: 3/23/2021

Max Credits: 1.5

View Activity

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/18/2021

Max Credits: 0.75

View Activity

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/16/2021

Max Credits: 2.25

View Activity

Chronic Lymphocytic Leukemia and Multiple Myeloma in the Community: Improving Outcomes with the Latest Clinical Advances

Chronic Lymphocytic Leukemia and Multiple Myeloma in the Community: Improving Outcomes with the Latest Clinical Advances

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/9/2021

Max Credits: 1.25

View Activity

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/26/2021

Max Credits: 1

View Activity

2019 Texas Oncology Clinical Educational Symposium

2019 Texas Oncology Clinical Educational Symposium

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 6/27/2020

Max Credits: 0

View Activity

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly dia…

Expiration Date: 6/10/2020

Max Credits: 0

View Activity

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 0

View Activity